• Stattic and STAT3: From Mechanism to Assay Design

  2026-08-25

  Stattic is a research-grade STAT3 inhibitor for dissecting phosphorylation, dimerization, nuclear signaling, apoptosis induction, and radiosensitization. This guide connects HNSCC assay design with mechanistic insights from a 2026 STING–STAT3–autophagy study while clearly separating validated evidence from translational hypotheses.

• 5-Azacytidine Workflow for DNA Demethylation

  2026-08-25

  Build reproducible 5-Azacytidine experiments that connect DNA demethylation with DNA-damage signaling and apoptosis. This workflow supports concentration-response studies, resistant multiple myeloma models, leukemia assays, and rational combination testing.

• n-Dodecyl-β-D-maltoside for Cryo-EM Assays

  2026-08-24

  Discover how n-Dodecyl-β-D-maltoside (DDM) can be selected and controlled as a structural biology detergent for membrane-protein cryo-EM, folding, and functional assays. Using recent full-length αvβ3 integrin structures, this article explains how detergent conditions can influence the interpretation of conformational heterogeneity.

• Dacarbazine: Oncology Assay Workflows

  2026-08-24

  Build reproducible Dacarbazine cytotoxicity studies with controlled stock preparation, exposure timing, DNA-damage readouts, and recovery measurements. The workflow also connects chemotherapy assay design with antiemetic evidence, helping researchers separate tumor-cell effects from treatment-associated nausea and vomiting questions.

• Peroxynitrite, Ca2+ Flux, and Cardiac Necroptosis

  2026-08-23

  Liu et al. identify a mechanistic link between hyperhomocysteinemia and cardiac microvascular ischemia–reperfusion injury: peroxynitrite-driven ER stress promotes IP3R-dependent Ca2+ transfer to mitochondria, oxidative amplification, and endothelial necroptosis. The study combines H/R cell experiments with rat I/R models and highlights IP3R-mediated Ca2+ handling as a tractable point for investigating microvascular injury.

• L-Ornithine for Liver–Brain Metabolism Research

  2026-08-22

  L-Ornithine supports reproducible studies of OTC activity, nitrogen disposal, and liver–brain metabolic signaling. This workflow-focused guide shows how to use the compound in aqueous assays, astrocyte models, and mechanistic toxicity experiments while avoiding solvent, concentration, and interpretation errors.

• Direct Mouse Genotyping Kit: Practical PCR Workflow

  2026-08-22

  The Direct Mouse Genotyping Kit supports direct PCR amplification from mouse tissue lysates, avoiding conventional DNA purification for routine allele detection, colony management, and high-throughput genotyping. It is intended for defined PCR-based genotyping and should not be treated as a replacement for purified genomic DNA when samples are needed for sequencing, quantitative analysis, or other downstream applications.

• Biotin-HPDP for Reversible Thiol Mapping

  2026-08-21

  Biotin-HPDP enables reversible thiol-specific protein labeling for redox and lipidation studies. This article connects its assay chemistry to the SELENOK–CD36 pathway in microglial Aβ phagocytosis and explains how to interpret capture results without confusing labeling with biological causality.

• Spatial Sampling of Disease in Ambrosia Beetle Colonies

  2026-08-20

  This open-access STAR Protocols paper presents an integrated workflow for rearing Xyleborus affinis, applying Metarhizium infection assays, testing vertical and horizontal transmission, and mapping microbes across colony habitats. Its main contribution is methodological: combining spatial sampling, culturable microbial quantification, fluorescence imaging, and cryo-sectioning to make infection dynamics in social beetle colonies experimentally tractable.

• Galectin-1–FIP200 Axis in Hepatic Steatosis

  2026-08-20

  A 2026 study identifies galectin-1 as an upstream suppressor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. By combining mouse models, proteomics, binding analysis, structural mapping, and interaction-disrupting mutations, the work defines the Gal-1–FIP200 axis as a mechanistic target for metabolic liver disease research.

• Ionophore Toxicity in Animals: Mechanisms and Risk

  2026-08-19

  Ekinci, Chłodowska, and Olejnik integrate clinical observations with molecular evidence to explain how polyether ionophores disrupt ion gradients, oxidative phosphorylation, and muscle-cell integrity in animals. The review also highlights species, age, dose, and tiamulin-interaction effects, providing a framework for safer veterinary study design and interpretation.

• Alpha-Ketoglutarate Workflows in Tumor Metabolism

  2026-08-19

  Use alpha-ketoglutarate as a controlled metabolic perturbation to connect TCA-cycle flux, nitrogen handling, enzyme activity, and macrophage signaling. This workflow translates a cholangiocarcinoma study into practical assay designs, concentration planning, controls, and troubleshooting steps for reproducible metabolic reprogramming research.

• Bazedoxifene as an Antimalarial: Hemozoin Inhibition

  2026-08-18

  The reference study identifies bazedoxifene, a third-generation selective estrogen receptor modulator, as an inhibitor of Plasmodium growth in erythrocytes and mice. Its strongest activity occurred during the ring stage and was associated with reduced hemozoin formation, supporting drug repurposing while highlighting sex-dependent differences in host-mediated efficacy.

• O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-08-18

  The reference study identifies O-GlcNAcylation as a metabolic and post-translational mechanism through which Wnt3a promotes osteoblastogenesis and bone repair. Its central finding is that Wnt stabilizes PDK1 through modification at Ser174, increasing aerobic glycolysis and linking Wnt signaling to glucose metabolism.

• Developmental SSRI Exposure and Motivation Deficits

  2026-08-17

  A 2026 Columbia dissertation shows that developmental SSRI exposure produces a selective motivational deficit in adolescent and adult mice, while reward liking and Pavlovian learning remain comparatively intact. Its most distinctive finding is that mu opioid receptor antagonism or nucleus accumbens knockdown can attenuate the deficit, identifying opioid-reward circuitry as a potential mechanistic target distinct from repeated SSRI treatment.

7995 records 3/533 page Previous Next 12345 下5页 Last page